Decision of the EEA Joint Committee No 86/2023 of 28 April 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2241]

Official Journal EN of the European Union L series 2023/2241 9.11.2023 DECISION OF THE EEA JOINT COMMITTEE No 86/2023 of 28 April 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2241] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Decision (EU) 2022/2325 of 24 November 2022 not approving 1,2-benzisothiazol-3

(2H)-one (BIT) as an active substance for use in biocidal products of product-type 10 in accordance with Regulation

(EU) No 528/2012 of the European Parliament and of the Council(1)is to be incorporated into the EEA Agreement.

(2) Commission Implementing Decision (EU) 2022/2326 of 24 November 2022not approving epsilon-metofluthrin as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(2)is to be incorporated into the EEA Agreement.

(3) Commission Implementing Decision (EU) 2022/2327 of 24 November 2022 not approving chloramin B as an active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(3)is to be incorporated into the EEA Agreement.

(4) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1 The following points are inserted after point 12zzzzzzzzo (Commission Implementing Decision (EU) 2022/1485) of

Chapter XV of Annex II to the EEA Agreement: ‘12zzzzzzzzp. 32022 D 2325: Commission Implementing Decision (EU) 2022/2325 of 24 November 2022 not approving 1,2-benzisothiazol-3(2H)-one (BIT) as an active substance for use in biocidal products of product-type 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 307, 28.11.2022, p. 267).

12zzzzzzzzq. 32022 D 2326: Commission Implementing Decision (EU) 2022/2326 of 24 November 2022 not approving epsilon-metofluthrin as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 307,

28.11.2022, p. 269).

12zzzzzzzzr. 32022 D 2327: Commission Implementing Decision (EU) 2022/2327 of 24 November 2022 not approving chloramin B as an active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 307,

28.11.2022, p. 271).’

(1) OJ L 307, 28.11.2022, p. 267.

(2) OJ L 307, 28.11.2022, p. 269.

(3) OJ L 307, 28.11.2022, p. 271.

ELI: http://data.europa.eu/eli/dec/2023/2241/oj 1/2EN OJ L, 9.11.2023 Article 2 The texts of Implementing Decisions (EU) 2022/2325, (EU) 2022/2326 and (EU) 2022/2327 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3 This Decision shall enter into force on 29 April 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made*.

Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 28 April 2023.

For the EEA Joint Committee The President Nicolas VON LINGEN * No constitutional requirements indicated.

2/2 ELI: http://data.europa.eu/eli/dec/2023/2241/oj